BioCrossroads
Overview
BioCrossroads is a public-private collaborative initiative dedicated to advancing Indiana's life sciences industry. While its scope is broad, a primary function is acting as a venture capital investor by forming and managing a series of return-driven, early-stage seed funds. These funds focus on Indiana-based companies in sectors including biotechnology, pharmaceuticals, medical devices, diagnostics, ag-biotech, and health information technology. The organization also helps create new enterprises and connects corporate, academic, and philanthropic partners.
Portfolio Companies
7
Website
biocrossroads.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gate Neurosciences | Sep 2022 | Convertible Debt | Co-investor |
| Lumavate | Feb 2022 | VC Round | Co-investor |
| Kovina Therapeutics | Oct 2021 | Seed | Co-investor |
| MBX Biosciences | Jul 2020 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Vince Wong
CEO and President
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioCrossroads based?
BioCrossroads is headquartered in Indianapolis, Indiana, United States.
When was BioCrossroads founded?
Founding year information for BioCrossroads is not publicly available.
How many portfolio companies does BioCrossroads have?
BioCrossroads has 7 portfolio companies in Caplight's dataset.
What are some companies in BioCrossroads's portfolio?
Recent investments visible on Caplight include Gate Neurosciences, Lumavate, Kovina Therapeutics, MBX Biosciences, MBX Biosciences.
What was BioCrossroads's most recent investment?
BioCrossroads's most recent investment on Caplight was in Gate Neurosciences in 2022.
What sectors does BioCrossroads focus on?
BioCrossroads focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does BioCrossroads focus on?
Stage focus information for BioCrossroads is not publicly available.
What is BioCrossroads's AUM?
BioCrossroads's assets under management are estimated between $23.3M and $24.3M.